RT @doctorRBC: DISCOVER-2 (52 wk study)Guselkumab 100mg q4wk and q8wk for tx of PsA1️⃣Sustained responses in: ACR2
Tweet Content
DISCOVER-2 (52 wk study) Guselkumab 100mg q4wk and q8wk for tx of PsA 1️⃣Sustained responses in: ACR20/50/70, PASI90/100, HAQ-DI, MDA/VLDA, QoL 2️⃣Improvement enthesitis/dactylitis 3️⃣No increase rate of serious infection @RheumNow #ACR20 Abs#0506 https://t.co/7MXYTucVZ9
Show on Archive Page
On
Display in Search Results
On